A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer

Clinical trial NCT02448771 · COMPLETED

Trial details

NCT number: NCT02448771
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Stage IV Unresectable Locally Advanced Invasive Breast Cancer Metastatic Invasive Breast Cancer

Start date: 2015-07-09
Primary completion: 2019-08-12
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.